Site #172 — Pittsburgh, Pennsylvania

Site #172 is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Site #172 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Pancreatic Ductal Adenocarcinoma.

Sponsors: Corcept Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pittsburgh

Browse all research sites in Pennsylvania · View every site in Pittsburgh

• University of Pittsburgh Cancer Institute, William M. Cooper Ambulatory Pavilion of the Hillman Cancer Center
• UPMC Presbyterian Shadyside Hospital
• University of Pittsburgh Physicians
• University of Pittsburgh Division of Pulmonary
• ENT Department, Children's Hospital of Pittsburgh
• Site US10167 University of Pittsburgh Medical Center
• University of Pittsburgh Medical Center, CHF/Transplantation Cardiology
• UPMC Children's Hospital
• Duplicate_Allegheny General Hospital /ID# 215585
• University of Pittsburgh MC /ID# 65486
• UPMC Hillman Cancer Center, Magee-Womens Hospital
• University of Pittsburgh Medical Center Department of Dermatology

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site #172?

Site #172 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site #172 conducted?

Site #172 has 1 clinical trials on record. Their work covers Metastatic Pancreatic Ductal Adenocarcinoma.

Is Site #172 accredited by Crixeo Clinical Trials?

Site #172 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site #172?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.